nodes	percent_of_prediction	percent_of_DWPC	metapath
Butorphanol—Ear disorder—Mesalazine—Crohn's disease	0.0172	0.0334	CcSEcCtD
Butorphanol—OPRD1—Peptide GPCRs—CCR9—Crohn's disease	0.0136	0.028	CbGpPWpGaD
Butorphanol—Withdrawal symptom—Prednisone—Crohn's disease	0.012	0.0233	CcSEcCtD
Butorphanol—OPRK1—Peptide GPCRs—CCR9—Crohn's disease	0.0119	0.0246	CbGpPWpGaD
Butorphanol—Hyperaesthesia—Mesalazine—Crohn's disease	0.0118	0.023	CcSEcCtD
Butorphanol—Feeling hot—Mesalazine—Crohn's disease	0.0118	0.023	CcSEcCtD
Butorphanol—Vasodilation—Mesalazine—Crohn's disease	0.0106	0.0205	CcSEcCtD
Butorphanol—Vasodilation procedure—Mesalazine—Crohn's disease	0.0106	0.0205	CcSEcCtD
Butorphanol—OPRM1—Peptide GPCRs—CCR9—Crohn's disease	0.0101	0.0208	CbGpPWpGaD
Butorphanol—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.01	0.0195	CcSEcCtD
Butorphanol—OPRD1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00974	0.0201	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00923	0.019	CbGpPWpGaD
Butorphanol—Abnormal dreams—Mesalazine—Crohn's disease	0.00917	0.0178	CcSEcCtD
Butorphanol—OPRD1—Peptide GPCRs—CCR6—Crohn's disease	0.00901	0.0186	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00854	0.0176	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00809	0.0167	CbGpPWpGaD
Butorphanol—OPRK1—Peptide GPCRs—CCR6—Crohn's disease	0.0079	0.0163	CbGpPWpGaD
Butorphanol—Ear pain—Mesalazine—Crohn's disease	0.0079	0.0153	CcSEcCtD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00762	0.0157	CbGpPWpGaD
Butorphanol—Deafness—Mesalazine—Crohn's disease	0.00753	0.0146	CcSEcCtD
Butorphanol—Eye pain—Mesalazine—Crohn's disease	0.00746	0.0145	CcSEcCtD
Butorphanol—OPRM1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00722	0.0149	CbGpPWpGaD
Butorphanol—Increased appetite—Mesalazine—Crohn's disease	0.00717	0.0139	CcSEcCtD
Butorphanol—Thirst—Mesalazine—Crohn's disease	0.00708	0.0138	CcSEcCtD
Butorphanol—Delusion—Prednisone—Crohn's disease	0.00694	0.0135	CcSEcCtD
Butorphanol—Lethargy—Mesalazine—Crohn's disease	0.00687	0.0134	CcSEcCtD
Butorphanol—OPRM1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00684	0.0141	CbGpPWpGaD
Butorphanol—Osteoarthritis—Mesalazine—Crohn's disease	0.00674	0.0131	CcSEcCtD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00669	0.0138	CbGpPWpGaD
Butorphanol—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00668	0.013	CcSEcCtD
Butorphanol—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.00668	0.0138	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00653	0.0135	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.0064	0.0132	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00619	0.0128	CbGpPWpGaD
Butorphanol—Abdominal pain upper—Mesalazine—Crohn's disease	0.00615	0.012	CcSEcCtD
Butorphanol—Oedema—Mercaptopurine—Crohn's disease	0.0061	0.0119	CcSEcCtD
Butorphanol—Petechiae—Prednisone—Crohn's disease	0.00597	0.0116	CcSEcCtD
Butorphanol—Dysphagia—Mesalazine—Crohn's disease	0.00582	0.0113	CcSEcCtD
Butorphanol—Anorexia—Mercaptopurine—Crohn's disease	0.00582	0.0113	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00573	0.0118	CbGpPWpGaD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00565	0.0116	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00561	0.0116	CbGpPWpGaD
Butorphanol—Bronchitis—Mesalazine—Crohn's disease	0.0056	0.0109	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00543	0.0112	CbGpPWpGaD
Butorphanol—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00541	0.0105	CcSEcCtD
Butorphanol—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.0054	0.0111	CbGpPWpGaD
Butorphanol—Decreased appetite—Mercaptopurine—Crohn's disease	0.0053	0.0103	CcSEcCtD
Butorphanol—Depression—Mesalazine—Crohn's disease	0.00518	0.0101	CcSEcCtD
Butorphanol—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.00506	0.0104	CbGpPWpGaD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00501	0.0103	CbGpPWpGaD
Butorphanol—Sweating—Mesalazine—Crohn's disease	0.00498	0.00967	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00497	0.0102	CbGpPWpGaD
Butorphanol—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.00495	0.0102	CbGpPWpGaD
Butorphanol—Epistaxis—Mesalazine—Crohn's disease	0.0049	0.00951	CcSEcCtD
Butorphanol—Sinusitis—Mesalazine—Crohn's disease	0.00487	0.00946	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00484	0.00998	CbGpPWpGaD
Butorphanol—Body temperature increased—Mercaptopurine—Crohn's disease	0.00482	0.00937	CcSEcCtD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00474	0.00977	CbGpPWpGaD
Butorphanol—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00473	0.00975	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.00472	0.00972	CbGpPWpGaD
Butorphanol—Rhinitis—Mesalazine—Crohn's disease	0.00467	0.00908	CcSEcCtD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00466	0.0096	CbGpPWpGaD
Butorphanol—Pharyngitis—Mesalazine—Crohn's disease	0.00463	0.00899	CcSEcCtD
Butorphanol—Chills—Azathioprine—Crohn's disease	0.00459	0.00892	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00459	0.00946	CbGpPWpGaD
Butorphanol—Arrhythmia—Azathioprine—Crohn's disease	0.00457	0.00888	CcSEcCtD
Butorphanol—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.00454	0.00935	CbGpPWpGaD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00439	0.00905	CbGpPWpGaD
Butorphanol—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.00439	0.00905	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00436	0.00899	CbGpPWpGaD
Butorphanol—Eye disorder—Mesalazine—Crohn's disease	0.00436	0.00846	CcSEcCtD
Butorphanol—Tinnitus—Mesalazine—Crohn's disease	0.00435	0.00844	CcSEcCtD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00429	0.00884	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00424	0.00873	CbGpPWpGaD
Butorphanol—Euphoric mood—Prednisone—Crohn's disease	0.00422	0.0082	CcSEcCtD
Butorphanol—Chills—Mesalazine—Crohn's disease	0.00418	0.00812	CcSEcCtD
Butorphanol—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.00413	0.00852	CbGpPWpGaD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00408	0.00842	CbGpPWpGaD
Butorphanol—Erythema—Mesalazine—Crohn's disease	0.00406	0.00788	CcSEcCtD
Butorphanol—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.004	0.00824	CbGpPWpGaD
Butorphanol—Flatulence—Mesalazine—Crohn's disease	0.004	0.00777	CcSEcCtD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00399	0.00822	CbGpPWpGaD
Butorphanol—Tension—Mesalazine—Crohn's disease	0.00398	0.00773	CcSEcCtD
Butorphanol—Nervousness—Mesalazine—Crohn's disease	0.00394	0.00766	CcSEcCtD
Butorphanol—Back pain—Mesalazine—Crohn's disease	0.00392	0.00762	CcSEcCtD
Butorphanol—Muscle spasms—Mesalazine—Crohn's disease	0.0039	0.00758	CcSEcCtD
Butorphanol—Vomiting—Mercaptopurine—Crohn's disease	0.00388	0.00754	CcSEcCtD
Butorphanol—Injury—Prednisone—Crohn's disease	0.00388	0.00753	CcSEcCtD
Butorphanol—Rash—Mercaptopurine—Crohn's disease	0.00385	0.00747	CcSEcCtD
Butorphanol—Dermatitis—Mercaptopurine—Crohn's disease	0.00384	0.00747	CcSEcCtD
Butorphanol—Vision blurred—Mesalazine—Crohn's disease	0.00382	0.00743	CcSEcCtD
Butorphanol—Tremor—Mesalazine—Crohn's disease	0.0038	0.00738	CcSEcCtD
Butorphanol—Increased appetite—Prednisone—Crohn's disease	0.00379	0.00737	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00376	0.00776	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00372	0.00766	CbGpPWpGaD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00371	0.00765	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.00369	0.0076	CbGpPWpGaD
Butorphanol—Vertigo—Mesalazine—Crohn's disease	0.00364	0.00708	CcSEcCtD
Butorphanol—Syncope—Mesalazine—Crohn's disease	0.00364	0.00707	CcSEcCtD
Butorphanol—Lethargy—Prednisone—Crohn's disease	0.00364	0.00707	CcSEcCtD
Butorphanol—Nausea—Mercaptopurine—Crohn's disease	0.00362	0.00704	CcSEcCtD
Butorphanol—Palpitations—Mesalazine—Crohn's disease	0.00359	0.00697	CcSEcCtD
Butorphanol—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00358	0.00737	CbGpPWpGaD
Butorphanol—Loss of consciousness—Mesalazine—Crohn's disease	0.00357	0.00693	CcSEcCtD
Butorphanol—Osteoarthritis—Prednisone—Crohn's disease	0.00356	0.00692	CcSEcCtD
Butorphanol—Cough—Mesalazine—Crohn's disease	0.00354	0.00688	CcSEcCtD
Butorphanol—Hypertension—Mesalazine—Crohn's disease	0.0035	0.00681	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0035	0.00721	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.00349	0.0072	CbGpPWpGaD
Butorphanol—Chest pain—Mesalazine—Crohn's disease	0.00345	0.00671	CcSEcCtD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00345	0.00711	CbGpPWpGaD
Butorphanol—Anxiety—Mesalazine—Crohn's disease	0.00344	0.00669	CcSEcCtD
Butorphanol—Hypotension—Azathioprine—Crohn's disease	0.0034	0.0066	CcSEcCtD
Butorphanol—Dry mouth—Mesalazine—Crohn's disease	0.00338	0.00656	CcSEcCtD
Butorphanol—Confusional state—Mesalazine—Crohn's disease	0.00334	0.00649	CcSEcCtD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00332	0.00684	CbGpPWpGaD
Butorphanol—Oedema—Mesalazine—Crohn's disease	0.00331	0.00643	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.00327	0.00674	CbGpPWpGaD
Butorphanol—Shock—Mesalazine—Crohn's disease	0.00326	0.00633	CcSEcCtD
Butorphanol—Tachycardia—Mesalazine—Crohn's disease	0.00323	0.00628	CcSEcCtD
Butorphanol—Hyperhidrosis—Mesalazine—Crohn's disease	0.0032	0.00622	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00318	0.00655	CbGpPWpGaD
Butorphanol—Anorexia—Mesalazine—Crohn's disease	0.00316	0.00613	CcSEcCtD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00314	0.00647	CbGpPWpGaD
Butorphanol—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00314	0.00646	CbGpPWpGaD
Butorphanol—Hypotension—Mesalazine—Crohn's disease	0.00309	0.00601	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.00304	0.00626	CbGpPWpGaD
Butorphanol—Feeling abnormal—Azathioprine—Crohn's disease	0.003	0.00582	CcSEcCtD
Butorphanol—Insomnia—Mesalazine—Crohn's disease	0.00299	0.00582	CcSEcCtD
Butorphanol—Paraesthesia—Mesalazine—Crohn's disease	0.00297	0.00578	CcSEcCtD
Butorphanol—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00297	0.00577	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00296	0.00609	CbGpPWpGaD
Butorphanol—Dyspnoea—Mesalazine—Crohn's disease	0.00295	0.00574	CcSEcCtD
Butorphanol—Somnolence—Mesalazine—Crohn's disease	0.00294	0.00572	CcSEcCtD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00292	0.00602	CbGpPWpGaD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00291	0.006	CbGpPWpGaD
Butorphanol—Decreased appetite—Mesalazine—Crohn's disease	0.00288	0.00559	CcSEcCtD
Butorphanol—Body temperature increased—Azathioprine—Crohn's disease	0.00287	0.00558	CcSEcCtD
Butorphanol—Abdominal pain—Azathioprine—Crohn's disease	0.00287	0.00558	CcSEcCtD
Butorphanol—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.00287	0.00591	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00284	0.00586	CbGpPWpGaD
Butorphanol—Constipation—Mesalazine—Crohn's disease	0.00283	0.0055	CcSEcCtD
Butorphanol—Depression—Prednisone—Crohn's disease	0.00274	0.00532	CcSEcCtD
Butorphanol—Feeling abnormal—Mesalazine—Crohn's disease	0.00273	0.0053	CcSEcCtD
Butorphanol—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.00272	0.0056	CbGpPWpGaD
Butorphanol—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00271	0.00526	CcSEcCtD
Butorphanol—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.00266	0.00549	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.00266	0.00549	CbGpPWpGaD
Butorphanol—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00265	0.00546	CbGpPWpGaD
Butorphanol—Urticaria—Mesalazine—Crohn's disease	0.00263	0.00511	CcSEcCtD
Butorphanol—Body temperature increased—Mesalazine—Crohn's disease	0.00262	0.00509	CcSEcCtD
Butorphanol—Abdominal pain—Mesalazine—Crohn's disease	0.00262	0.00509	CcSEcCtD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00256	0.00528	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.00255	0.00526	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0025	0.00516	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00249	0.00514	CbGpPWpGaD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00246	0.00507	CbGpPWpGaD
Butorphanol—Hallucination—Prednisone—Crohn's disease	0.00245	0.00477	CcSEcCtD
Butorphanol—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00242	0.00499	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.00242	0.00499	CbGpPWpGaD
Butorphanol—Dizziness—Azathioprine—Crohn's disease	0.0024	0.00467	CcSEcCtD
Butorphanol—Asthenia—Mesalazine—Crohn's disease	0.00238	0.00462	CcSEcCtD
Butorphanol—Pruritus—Mesalazine—Crohn's disease	0.00234	0.00455	CcSEcCtD
Butorphanol—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.00234	0.00482	CbGpPWpGaD
Butorphanol—Vomiting—Azathioprine—Crohn's disease	0.00231	0.00449	CcSEcCtD
Butorphanol—Eye disorder—Prednisone—Crohn's disease	0.0023	0.00448	CcSEcCtD
Butorphanol—Rash—Azathioprine—Crohn's disease	0.00229	0.00445	CcSEcCtD
Butorphanol—Dermatitis—Azathioprine—Crohn's disease	0.00229	0.00445	CcSEcCtD
Butorphanol—Headache—Azathioprine—Crohn's disease	0.00228	0.00442	CcSEcCtD
Butorphanol—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00225	0.00464	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.00224	0.00461	CbGpPWpGaD
Butorphanol—Arrhythmia—Prednisone—Crohn's disease	0.0022	0.00428	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00219	0.00452	CbGpPWpGaD
Butorphanol—Dizziness—Mesalazine—Crohn's disease	0.00219	0.00425	CcSEcCtD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00217	0.00446	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.00217	0.00446	CbGpPWpGaD
Butorphanol—Nausea—Azathioprine—Crohn's disease	0.00216	0.00419	CcSEcCtD
Butorphanol—Erythema—Prednisone—Crohn's disease	0.00215	0.00417	CcSEcCtD
Butorphanol—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.00212	0.00437	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00211	0.00434	CbGpPWpGaD
Butorphanol—Vomiting—Mesalazine—Crohn's disease	0.00211	0.00409	CcSEcCtD
Butorphanol—Rash—Mesalazine—Crohn's disease	0.00209	0.00406	CcSEcCtD
Butorphanol—Dermatitis—Mesalazine—Crohn's disease	0.00209	0.00405	CcSEcCtD
Butorphanol—Headache—Mesalazine—Crohn's disease	0.00207	0.00403	CcSEcCtD
Butorphanol—Vision blurred—Prednisone—Crohn's disease	0.00202	0.00393	CcSEcCtD
Butorphanol—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.00197	0.00407	CbGpPWpGaD
Butorphanol—Agitation—Prednisone—Crohn's disease	0.00197	0.00383	CcSEcCtD
Butorphanol—Nausea—Mesalazine—Crohn's disease	0.00197	0.00382	CcSEcCtD
Butorphanol—Vertigo—Prednisone—Crohn's disease	0.00193	0.00375	CcSEcCtD
Butorphanol—Syncope—Prednisone—Crohn's disease	0.00192	0.00374	CcSEcCtD
Butorphanol—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.00191	0.00394	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.00191	0.00393	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.0019	0.00391	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00189	0.0039	CbGpPWpGaD
Butorphanol—Loss of consciousness—Prednisone—Crohn's disease	0.00189	0.00367	CcSEcCtD
Butorphanol—Convulsion—Prednisone—Crohn's disease	0.00186	0.00361	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00186	0.00382	CbGpPWpGaD
Butorphanol—Hypertension—Prednisone—Crohn's disease	0.00185	0.0036	CcSEcCtD
Butorphanol—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.00185	0.00381	CbGpPWpGaD
Butorphanol—Anxiety—Prednisone—Crohn's disease	0.00182	0.00354	CcSEcCtD
Butorphanol—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.00179	0.0037	CbGpPWpGaD
Butorphanol—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00177	0.00364	CbGpPWpGaD
Butorphanol—Oedema—Prednisone—Crohn's disease	0.00175	0.0034	CcSEcCtD
Butorphanol—Shock—Prednisone—Crohn's disease	0.00172	0.00335	CcSEcCtD
Butorphanol—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.00172	0.00354	CbGpPWpGaD
Butorphanol—Tachycardia—Prednisone—Crohn's disease	0.00171	0.00332	CcSEcCtD
Butorphanol—Hyperhidrosis—Prednisone—Crohn's disease	0.00169	0.00329	CcSEcCtD
Butorphanol—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.00168	0.00346	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.00167	0.00344	CbGpPWpGaD
Butorphanol—Anorexia—Prednisone—Crohn's disease	0.00167	0.00324	CcSEcCtD
Butorphanol—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.00162	0.00334	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.0016	0.00331	CbGpPWpGaD
Butorphanol—Insomnia—Prednisone—Crohn's disease	0.00158	0.00308	CcSEcCtD
Butorphanol—Paraesthesia—Prednisone—Crohn's disease	0.00157	0.00306	CcSEcCtD
Butorphanol—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.00156	0.00321	CbGpPWpGaD
Butorphanol—Decreased appetite—Prednisone—Crohn's disease	0.00152	0.00296	CcSEcCtD
Butorphanol—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.00151	0.00311	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.00151	0.0031	CbGpPWpGaD
Butorphanol—Constipation—Prednisone—Crohn's disease	0.0015	0.00291	CcSEcCtD
Butorphanol—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.00147	0.00303	CbGpPWpGaD
Butorphanol—Feeling abnormal—Prednisone—Crohn's disease	0.00144	0.0028	CcSEcCtD
Butorphanol—Gastrointestinal pain—Prednisone—Crohn's disease	0.00143	0.00278	CcSEcCtD
Butorphanol—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.00143	0.00295	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00141	0.00291	CbGpPWpGaD
Butorphanol—Urticaria—Prednisone—Crohn's disease	0.00139	0.0027	CcSEcCtD
Butorphanol—Abdominal pain—Prednisone—Crohn's disease	0.00138	0.00269	CcSEcCtD
Butorphanol—Body temperature increased—Prednisone—Crohn's disease	0.00138	0.00269	CcSEcCtD
Butorphanol—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00137	0.00282	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.00137	0.00282	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00137	0.00281	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.00132	0.00272	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.00131	0.00269	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00127	0.00262	CbGpPWpGaD
Butorphanol—Asthenia—Prednisone—Crohn's disease	0.00126	0.00244	CcSEcCtD
Butorphanol—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.00125	0.00258	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00124	0.00256	CbGpPWpGaD
Butorphanol—Pruritus—Prednisone—Crohn's disease	0.00124	0.00241	CcSEcCtD
Butorphanol—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.00122	0.00252	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.0012	0.00247	CbGpPWpGaD
Butorphanol—Dizziness—Prednisone—Crohn's disease	0.00116	0.00225	CcSEcCtD
Butorphanol—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00116	0.00238	CbGpPWpGaD
Butorphanol—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00115	0.00237	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.00115	0.00236	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00114	0.00235	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.00112	0.0023	CbGpPWpGaD
Butorphanol—Vomiting—Prednisone—Crohn's disease	0.00111	0.00216	CcSEcCtD
Butorphanol—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.00111	0.00229	CbGpPWpGaD
Butorphanol—Rash—Prednisone—Crohn's disease	0.0011	0.00215	CcSEcCtD
Butorphanol—Dermatitis—Prednisone—Crohn's disease	0.0011	0.00214	CcSEcCtD
Butorphanol—Headache—Prednisone—Crohn's disease	0.0011	0.00213	CcSEcCtD
Butorphanol—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.00108	0.00223	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00108	0.00222	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.00107	0.00221	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.00106	0.00218	CbGpPWpGaD
Butorphanol—Nausea—Prednisone—Crohn's disease	0.00104	0.00202	CcSEcCtD
Butorphanol—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.00103	0.00213	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00101	0.00209	CbGpPWpGaD
Butorphanol—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00101	0.00208	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.001	0.00206	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000991	0.00204	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000978	0.00202	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000974	0.00201	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000969	0.002	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.00095	0.00196	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000945	0.00195	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000921	0.0019	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000918	0.00189	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000916	0.00189	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000907	0.00187	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000887	0.00183	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000869	0.00179	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000858	0.00177	CbGpPWpGaD
Butorphanol—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000854	0.00176	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000847	0.00175	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000833	0.00172	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000823	0.0017	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000808	0.00166	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000806	0.00166	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000805	0.00166	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000803	0.00166	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000803	0.00165	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000798	0.00165	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000778	0.0016	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000734	0.00151	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000731	0.00151	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000725	0.00149	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000707	0.00146	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000698	0.00144	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000683	0.00141	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.00068	0.0014	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000679	0.0014	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000658	0.00136	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000656	0.00135	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000643	0.00132	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000617	0.00127	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000612	0.00126	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000597	0.00123	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000594	0.00122	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000584	0.0012	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000578	0.00119	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000576	0.00119	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000564	0.00116	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000521	0.00107	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000521	0.00107	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000517	0.00107	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.000512	0.00105	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000507	0.00104	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000505	0.00104	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000492	0.00101	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000486	0.001	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000476	0.000982	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000476	0.000981	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000456	0.000941	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000443	0.000912	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.00044	0.000906	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000433	0.000891	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000432	0.00089	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000432	0.000889	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000431	0.000889	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000428	0.000882	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000417	0.00086	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000411	0.000847	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000394	0.000812	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000392	0.000808	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000386	0.000795	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.000379	0.000781	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000378	0.000779	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000374	0.000771	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000372	0.000767	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—IL3—Crohn's disease	0.000365	0.000752	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	0.000361	0.000743	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000358	0.000738	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000353	0.000727	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000346	0.000712	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000345	0.00071	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	0.000344	0.000709	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	0.000327	0.000673	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.00032	0.00066	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	0.00032	0.000659	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	0.000314	0.000647	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000305	0.000628	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	0.000302	0.000623	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000292	0.000602	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000291	0.000599	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000276	0.000569	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000265	0.000547	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000256	0.000527	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—TYK2—Crohn's disease	0.000243	0.000501	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—JAK2—Crohn's disease	0.000232	0.000478	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—TYK2—Crohn's disease	0.000213	0.000439	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000212	0.000436	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—JAK2—Crohn's disease	0.000203	0.000419	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—IL6—Crohn's disease	0.000201	0.000414	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	0.000185	0.000382	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—TYK2—Crohn's disease	0.00018	0.000371	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—IL6—Crohn's disease	0.000176	0.000363	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—JAK2—Crohn's disease	0.000172	0.000354	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—STAT3—Crohn's disease	0.00017	0.000351	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	0.000157	0.000323	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—STAT3—Crohn's disease	0.000149	0.000307	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—IL6—Crohn's disease	0.000149	0.000307	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—STAT3—Crohn's disease	0.000126	0.00026	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—IL6—Crohn's disease	0.000119	0.000245	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—IL6—Crohn's disease	0.000104	0.000215	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—IL6—Crohn's disease	8.81e-05	0.000181	CbGpPWpGaD
